Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Otezla (Apremilast), an Oral PDE-4 Inhibitor, Receives FDA Approval for the Treatment of Patients with Active Psoriatic Arthritis and Plaque Psoriasis.

Literature DB >> 26629274

Otezla (Apremilast), an Oral PDE-4 Inhibitor, Receives FDA Approval for the Treatment of Patients with Active Psoriatic Arthritis and Plaque Psoriasis.

Loretta Fala.

Abstract

Entities: Disease Gene Species

Year: 2015 PMID： 26629274 PMCID： PMC4665061

Source DB: PubMed Journal: Am Health Drug Benefits ISSN： 1942-2962

× No keyword cloud information.

4 in total

1. The burden of psoriatic arthritis: a literature review from a global health systems perspective.

Authors: Seina Lee; Alan Mendelsohn; Evelyn Sarnes
Journal: P T Date: 2010-12

2. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

Authors: D T Felson; J J Anderson; M Boers; C Bombardier; D Furst; C Goldsmith; L M Katz; R Lightfoot; H Paulus; V Strand
Journal: Arthritis Rheum Date: 1995-06

3. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011.

Authors: April W Armstrong; Clayton Schupp; Julie Wu; Bruce Bebo
Journal: PLoS One Date: 2012-12-28 Impact factor: 3.240

4. Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.

Authors: Arthur Kavanaugh; Philip J Mease; Juan J Gomez-Reino; Adewale O Adebajo; Jürgen Wollenhaupt; Dafna D Gladman; Eric Lespessailles; Stephen Hall; Marla Hochfeld; ChiaChi Hu; Douglas Hough; Randall M Stevens; Georg Schett
Journal: Ann Rheum Dis Date: 2014-03-04 Impact factor: 19.103

4 in total

15 in total

1. Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench.

Authors: Walter E Rodriguez; Banrida Wahlang; Yali Wang; Jingwen Zhang; Manicka V Vadhanam; Swati Joshi-Barve; Philip Bauer; Robert Cannon; Ali Reza Ahmadi; Zhaoli Sun; Andrew Cameron; Shirish Barve; Claudio Maldonado; Craig McClain; Leila Gobejishvili
Journal: Hepatology Date: 2019-06-25 Impact factor: 17.425

2. Effects of Apremilast on Induced Hypertrophic Scar of Rabbits.

Authors: D Nidhal Ghazy; A Rahmah Abu-Raghif
Journal: Arch Razi Inst Date: 2021-12-30

Review 3. Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.

Authors: Shuai Shao; Gang Wang; Emanual Maverakis; Johann E Gudjonsson
Journal: Drugs Date: 2020-04 Impact factor: 9.546

4. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis.

Authors: Diana V Avila; David F Barker; JingWen Zhang; Craig J McClain; Shirish Barve; Leila Gobejishvili
Journal: J Pathol Date: 2016-09 Impact factor: 7.996

Review 5. Systemic Treatment of Adult Atopic Dermatitis: A Review.

Authors: Matteo Megna; Maddalena Napolitano; Cataldo Patruno; Alessia Villani; Anna Balato; Giuseppe Monfrecola; Fabio Ayala; Nicola Balato
Journal: Dermatol Ther (Heidelb) Date: 2016-12-26

6. Use of FDA-Approved Medications: Biologics for Psoriatic Arthritis in Patients at an Urban Outpatient Rheumatology Clinic.

Authors: Ira Khanna; Orysia Kozicky; Harry Fischer
Journal: ACR Open Rheumatol Date: 2019-09-12

7. Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study.

Authors: Giovanna Malara; Cristina Politi; Caterina Trifirò; Chiara Verduci; Graziella D'Arrigo; Alessandra Testa; Giovanni Tripepi
Journal: Acta Derm Venereol Date: 2021-09-15 Impact factor: 3.875

Review 8. A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure.

Authors: Ryan P Ceddia; Sheila Collins
Journal: Clin Sci (Lond) Date: 2020-03-13 Impact factor: 6.876

Review 9. Psoriasis and inflammatory bowel disease: links and risks.

Authors: Christoforos Vlachos; Georgios Gaitanis; Konstantinos H Katsanos; Dimitrios K Christodoulou; Epameinondas Tsianos; Ioannis D Bassukas
Journal: Psoriasis (Auckl) Date: 2016-07-20

Review 10. Considerations for safety in the use of systemic medications for psoriasis and atopic dermatitis during the COVID-19 pandemic.

Authors: Jose W Ricardo; Shari R Lipner
Journal: Dermatol Ther Date: 2020-06-19 Impact factor: 3.858